商標ウォッチ

TOP｜特許｜意匠｜商標

商標ウォッチ Twitter

公開日2024-11-20
公報種別公開国際商標公報
国際登録番号1810451
国際登録日2024-07-08
区分第5類(薬剤),第44類(医療・農林業)
商品役務Pharmaceutical preparations for human use; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions.,Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders.
基礎出願番号98354433
基礎出願日2024-01-12
基礎出願国US
出願人Neurocrine Biosciences, Inc.
OCRテキスト
OCRテキスト2
OCRについて

この商標をJ-PlatPatで参照する

関連商標

Novo Nordisk A/S

Nant Holdings IP, LLC

MannKind Corporation

Roogenic Pty Ltd

Straumann Holding AG

MediBeacon Inc.

DayOne Performance GmbH

IDEAS OCEAN COMPANY LIMITED

Boegli-Gravures SA

Glanbia Nutritionals Limited

CAPTURE COLLECTIVE, INC.

Population Health Partners, L.P.

T.G. Eakin Limited

MannKind Corporation

Enterobiome Inc.

Koa Kids Pty Ltd

SpringWorks Therapeutics Operating Company, Inc.

LigaChem Biosciences Inc.

Zevra Denmark A/S

Tru Brands, Inc.

Gano Excel (China) Biotechnology Co.,Ltd

Beijing Scrianen Pharmaceutical Co., Ltd.

斯利安 SCRIANEN

BlueWhale Bio, Inc.

Tarsus Pharmaceuticals, Inc.

Solarea Bio, Inc.

Pure Salmon France SAS

Chrysea Labs Lda

T.G. Eakin Limited

Elevar Therapeutics, Inc.

Elevar Therapeutics, Inc.

Elevar Therapeutics, Inc.

続きを見る